192 related articles for article (PubMed ID: 17848193)
1. TGFB1 and TGFBR1 polymorphisms and breast cancer risk in the Nurses' Health Study.
Cox DG; Penney K; Guo Q; Hankinson SE; Hunter DJ
BMC Cancer; 2007 Sep; 7():175. PubMed ID: 17848193
[TBL] [Abstract][Full Text] [Related]
2. Genetic Polymorphisms of TGFB1, TGFBR1, SNAI1 and TWIST1 Are Associated with Endometrial Cancer Susceptibility in Chinese Han Women.
Yang L; Wang YJ; Zheng LY; Jia YM; Chen YL; Chen L; Liu DG; Li XH; Guo HY; Sun YL; Tian XX; Fang WG
PLoS One; 2016; 11(5):e0155270. PubMed ID: 27171242
[TBL] [Abstract][Full Text] [Related]
3. TGFB1 and TGFBR1 polymorphic variants in relationship to bladder cancer risk and prognosis.
Castillejo A; Rothman N; Murta-Nascimento C; Malats N; García-Closas M; Gómez-Martínez A; Lloreta J; Tardón A; Serra C; García-Closas R; Chanock S; Silverman DT; Dosemeci M; Kogevinas M; Carrato A; Soto JL; Real FX
Int J Cancer; 2009 Feb; 124(3):608-13. PubMed ID: 19004027
[TBL] [Abstract][Full Text] [Related]
4. Combined genetic assessment of transforming growth factor-beta signaling pathway variants may predict breast cancer risk.
Kaklamani VG; Baddi L; Liu J; Rosman D; Phukan S; Bradley C; Hegarty C; McDaniel B; Rademaker A; Oddoux C; Ostrer H; Michel LS; Huang H; Chen Y; Ahsan H; Offit K; Pasche B
Cancer Res; 2005 Apr; 65(8):3454-61. PubMed ID: 15833881
[TBL] [Abstract][Full Text] [Related]
5. Role of polymorphisms in Adamantiades-Behçet's disease.
Kaklamani VG; Sadim M; Koumantaki Y; Kaklamanis P; Pasche B
J Rheumatol; 2008 Dec; 35(12):2376-8. PubMed ID: 18925687
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in the transforming growth factor beta 1 pathway in relation to colorectal cancer progression.
Försti A; Li X; Wagner K; Tavelin B; Enquist K; Palmqvist R; Altieri A; Hallmans G; Hemminki K; Lenner P
Genes Chromosomes Cancer; 2010 Mar; 49(3):270-81. PubMed ID: 19998449
[TBL] [Abstract][Full Text] [Related]
7. TGFBR1 polymorphism and risk of breast cancer in Iranian women.
Kamali E; Hemmati S; Safari F; Tavassoli M
Int J Biol Markers; 2015 Nov; 30(4):e414-7. PubMed ID: 26165686
[TBL] [Abstract][Full Text] [Related]
8. Association between TGFBR1 polymorphisms and cancer risk: a meta-analysis of 35 case-control studies.
Wang YQ; Qi XW; Wang F; Jiang J; Guo QN
PLoS One; 2012; 7(8):e42899. PubMed ID: 22905183
[TBL] [Abstract][Full Text] [Related]
9. Resequencing of genes for transforming growth factor beta1 (TGFB1) type 1 and 2 receptors (TGFBR1, TGFBR2), and association analysis of variants with diabetic nephropathy.
McKnight AJ; Savage DA; Patterson CC; Sadlier D; Maxwell AP
BMC Med Genet; 2007 Feb; 8():5. PubMed ID: 17319955
[TBL] [Abstract][Full Text] [Related]
10. VEGF, FGF2, TGFB1 and TGFBR1 mRNA expression levels correlate with the malignant transformation of the uterine cervix.
Soufla G; Sifakis S; Baritaki S; Zafiropoulos A; Koumantakis E; Spandidos DA
Cancer Lett; 2005 Apr; 221(1):105-18. PubMed ID: 15797633
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor beta receptor II (TGFBR2) promoter region polymorphism in Brazilian breast cancer patients: association with susceptibility, clinicopathological features, and interaction with TGFB1 haplotypes.
Vitiello GAF; Amarante MK; Banin-Hirata BK; Campos CZ; de Oliveira KB; Losi-Guembarovski R; Watanabe MAE
Breast Cancer Res Treat; 2019 Nov; 178(1):207-219. PubMed ID: 31364002
[TBL] [Abstract][Full Text] [Related]
12. [Correlations of polymorphisms of TGFB1 and TGFBR2 genes to genetic susceptibility to gastric cancer].
Zhou Y; Jin GF; Jiang GJ; Wang HM; Tan YF; Ding WL; Wang LN; Chen WS; Ke Q; Shen J; Xu YC; Shen HB
Ai Zheng; 2007 Jun; 26(6):581-5. PubMed ID: 17562261
[TBL] [Abstract][Full Text] [Related]
13. TGFBR1(*)6A and Int7G24A variants of transforming growth factor-beta receptor 1 in Swedish familial and sporadic breast cancer.
Song B; Margolin S; Skoglund J; Zhou X; Rantala J; Picelli S; Werelius B; Lindblom A
Br J Cancer; 2007 Oct; 97(8):1175-9. PubMed ID: 17848956
[TBL] [Abstract][Full Text] [Related]
14. TGFB1 and TGFBR2 functional polymorphisms and risk of esophageal squamous cell carcinoma: a case-control analysis in a Chinese population.
Jin G; Deng Y; Miao R; Hu Z; Zhou Y; Tan Y; Wang J; Hua Z; Ding W; Wang L; Chen W; Shen J; Wang X; Xu Y; Shen H
J Cancer Res Clin Oncol; 2008 Mar; 134(3):345-51. PubMed ID: 17680270
[TBL] [Abstract][Full Text] [Related]
15. Involvement of transforming growth factor β and its type 1 receptor in the development of breast cancer.
Keshelava VV; Khodorovich OS; Shaykhaev GO; Chazova NL; Bereschanskaya AM
Bull Exp Biol Med; 2011 Nov; 152(1):98-100. PubMed ID: 22803051
[TBL] [Abstract][Full Text] [Related]
16. The TGFBR1*6A allele is not associated with susceptibility to colorectal cancer in a Spanish population: a case-control study.
Castillejo A; Mata-Balaguer T; Montenegro P; Ochoa E; Lázaro R; Martínez-Cantó A; Castillejo MI; Guarinos C; Barberá VM; Guillén-Ponce C; Carrato A; Soto JL
BMC Cancer; 2009 Jun; 9():193. PubMed ID: 19538729
[TBL] [Abstract][Full Text] [Related]
17. Somatic acquisition and signaling of TGFBR1*6A in cancer.
Pasche B; Knobloch TJ; Bian Y; Liu J; Phukan S; Rosman D; Kaklamani V; Baddi L; Siddiqui FS; Frankel W; Prior TW; Schuller DE; Agrawal A; Lang J; Dolan ME; Vokes EE; Lane WS; Huang CC; Caldes T; Di Cristofano A; Hampel H; Nilsson I; von Heijne G; Fodde R; Murty VV; de la Chapelle A; Weghorst CM
JAMA; 2005 Oct; 294(13):1634-46. PubMed ID: 16204663
[TBL] [Abstract][Full Text] [Related]
18. Association of polymorphisms in transforming growth factor-β receptors with susceptibility to gastric cardia adenocarcinoma.
Guo W; Dong Z; Guo Y; Chen Z; Yang Z; Kuang G
Mol Biol Rep; 2012 Apr; 39(4):4301-9. PubMed ID: 21785915
[TBL] [Abstract][Full Text] [Related]
19. Clinical utility of
Peres KC; Teodoro L; Amaral LHP; Teixeira ES; Barreto IS; de Freitas LLL; Maximo V; Assumpção LVM; Bufalo NE; Ward LS
Arch Endocrinol Metab; 2021 Nov; 65(2):172-184. PubMed ID: 33905626
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor beta 1 polymorphisms and haplotypes associated with breast cancer susceptibility: A case-control study in Tunisian women.
Hadj-Ahmed M; Ghali RM; Bouaziz H; Habel A; Stayoussef M; Ayedi M; Hachiche M; Rahal K; Yacoubi-Loueslati B; Almawi WY
Tumour Biol; 2019 Aug; 41(8):1010428319869096. PubMed ID: 31405342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
